REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
11.34
+0.42 (3.85%)
At close: Oct 13, 2025, 4:00 PM EDT
11.13
-0.21 (-1.85%)
Pre-market: Oct 14, 2025, 4:42 AM EDT

REGENXBIO Revenue

REGENXBIO had revenue of $21.36M in the quarter ending June 30, 2025, a decrease of -4.20%. This brings the company's revenue in the last twelve months to $155.78M, up 74.95% year-over-year. In the year 2024, REGENXBIO had annual revenue of $83.33M, down -7.66%.

Revenue (ttm)
$155.78M
Revenue Growth
+74.95%
P/S Ratio
3.72
Revenue / Employee
$441,309
Employees
353
Market Cap
572.83M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202483.33M-6.91M-7.66%
Dec 31, 202390.24M-22.48M-19.94%
Dec 31, 2022112.72M-357.62M-76.03%
Dec 31, 2021470.35M315.78M204.30%
Dec 31, 2020154.57M119.33M338.70%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro